A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy
Completed · Phase 3 · Has a placebo group
Conditions studied: Allergic Conjunctivitis
In brief
This study is researching 2 experimental drugs, REGN1908 and REGN1909, which are called REGN1908-1909 when mixed together (called "study drug") to reduce eye allergy signs and symptoms from cat allergy. The aim of the study is to see how safe and effective the study drug is at lowering allergic eye signs and symptoms compared with placebo. A placebo looks like a treatment but does not contain any real medicine. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)
Key facts
- Study ID
- NCT06602726
- Run by
- Regeneron Pharmaceuticals
- People needed
- 64
- Starts
- 2024-11-06
- Expected to finish
- 2025-08-02
- Last updated by the study team
- 2026-05-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Andover Eye Associates — Andover, Massachusetts, United States
- Kingston Health Sciences Centre — Kingston, Ontario, Canada
- Red Maple Trials Inc. — Ottawa, Ontario, Canada
- Clinique de Specialisee en Allergie de la Capitale — Québec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.